PFCS
Pale Fire Capital SE Portfolio holdings
AUM
$958M
1-Year Return
80.1%
This Quarter Return
+5.98%
1 Year Return
+80.1%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$717M
AUM Growth
+$77.9M
(+12%)
Cap. Flow
+$45M
Cap. Flow
% of AUM
6.27%
Top 10 Holdings %
Top 10 Hldgs %
87.13%
Holding
84
New
6
Increased
10
Reduced
18
Closed
28
Top Buys
| 1 |
Groupon
GRPN
|
+$41.9M |
| 2 |
Shell
SHEL
|
+$21.7M |
| 3 |
CGAU
Centerra Gold
CGAU
|
+$6.88M |
| 4 |
Alibaba
BABA
|
+$5.79M |
| 5 |
Teladoc Health
TDOC
|
+$5.3M |
Top Sells
| 1 |
BP
BP
|
+$12.6M |
| 2 |
Nomad Foods
NOMD
|
+$4.65M |
| 3 |
IAC Inc
IAC
|
+$4.29M |
| 4 |
Noble Corp
NE
|
+$4.11M |
| 5 |
TripAdvisor
TRIP
|
+$3.44M |
Sector Composition
| 1 | Energy | 46.96% |
| 2 | Communication Services | 23.64% |
| 3 | Consumer Staples | 14.77% |
| 4 | Consumer Discretionary | 4.54% |
| 5 | Industrials | 4.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MOMO
26
Hello Group
MOMO
$1.19B
| $675K | 0.09% |
+108,772
| New | +$675K |
|
27
Fortuna Silver Mines
FSM
$2.56B
| $522K | 0.07% |
140,000
| – | – |
|
28
ReNew
RNW
$2.76B
| $423K | 0.06% |
70,451
-9,749
| -12% | -$58.5K |
|
29
Mineralys Therapeutics
MLYS
$2.88B
| $373K | 0.05% |
28,915
-5,828
| -17% | -$75.2K |
|
30
uniQure
QURE
$904M
| $341K | 0.05% |
65,600
| – | – |
|
31
Compass Therapeutics
CMPX
$613M
| $249K | 0.03% |
125,968
-55,087
| -30% | -$109K |
|
32
Erasca
ERAS
$443M
| $231K | 0.03% |
111,906
-74,195
| -40% | -$153K |
|
33
Celcuity
CELC
$2.33B
| $222K | 0.03% |
10,269
-4,140
| -29% | -$89.4K |
|
34
Passage Bio
PASG
$22.3M
| $191K | 0.03% |
7,072
-21,991
| -76% | -$594K |
|
|
ATYR
35
aTyr Pharma
ATYR
$591M
| $178K | 0.02% |
91,232
-202,474
| -69% | -$395K |
|
36
TScan Therapeutics
TCRX
$99.9M
| $171K | 0.02% |
21,573
| – | – |
|
37
Black Diamond Therapeutics
BDTX
$185M
| $171K | 0.02% |
33,697
-17,403
| -34% | -$88.2K |
|
38
Iovance Biotherapeutics
IOVA
$821M
| $163K | 0.02% |
11,000
-6,024
| -35% | -$89.3K |
|
39
Prelude Therapeutics
PRLD
$64M
| $149K | 0.02% |
31,481
-32,100
| -50% | -$152K |
|
|
IGMS
40
DELISTED
IGM Biosciences
IGMS
| $112K | 0.02% |
11,601
| – | – |
|
41
Caribou Biosciences
CRBU
$168M
| $112K | 0.02% |
21,700
-6,500
| -23% | -$33.4K |
|
|
CMRX
42
DELISTED
Chimerix, Inc.
CMRX
| $111K | 0.02% |
104,796
-106,418
| -50% | -$113K |
|
43
Cidara Therapeutics
CDTX
$1.66B
| $61.2K | 0.01% |
3,327
| – | – |
|
44
X4 Pharmaceuticals
XFOR
$73.2M
| $52.9K | 0.01% |
+1,269
| New | +$52.9K |
|
|
FLG
45
Flagstar Financial, Inc.
FLG
$5.27B
| $36.1K | 0.01% |
+3,735
| New | +$36.1K |
|
46
Lucid Motors
LCID
$5.92B
| $29.6K | ﹤0.01% |
+1,040
| New | +$29.6K |
|
|
OKUR
47
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$33.1M
| – | – |
-3,010
| Closed | -$48.2K |
|
48
BioAtla
BCAB
$45.5M
| – | – |
-48,383
| Closed | -$119K |
|
|
49
BP
BP
$87.3B
| – | – |
-357,245
| Closed | -$12.6M |
|
50
CarGurus
CARG
$3.58B
| – | – |
-74,494
| Closed | -$1.8M |
|